UPDATE 1-Express Scripts to cover Mylan's EpiPen, exclude rivals

NEW YORK, July 31 (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies.